MCM2 and ovarian carcinoma: Our results showed that miR-367 inhibited the expression of MCM2, MMP2, MMP9, and VEGF, suggesting that miR-367 may repress tumor cell proliferation, migration, invasion, and angiogenesis in ovarian cancer.